Co-Diagnostics, Inc. (CODX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.74M |
| Enterprise Value | -3.9M |
| P/E Ratio | -0.01 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 2.29 |
| Price/Book Ratio | 0.18 |
| Enterprise/Revenue | 3.28 |
| Enterprise/EBITDA | -0.06 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -55.28 |
| Operating Margin | -34.16 |
AD
Management Effectiveness
| Return On Assets | -3.71 |
| Return On Equity | -3.23 |
Income Statement
| Revenue | 622,489 |
| Revenue/Share | 0.14 |
| Gross Profit | 400,112 |
| EBITDA | -47.41M |
| Net Income | -46.9M |
| Diluted EPS | -35.25 |
Balance Sheet
| Total Cash | 714,803 |
| Total Cash/Share | 0.11 |
| Total Debt | 1.56M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 0.77 |
| Book Value Per Share | 1.5 |
Price History
| 52-Week Change | -97.77 |
| 52-Week High | 13.54 |
| 52-Week Low | 0.25 |
| Moving Average 50 Days | 0.83 |
| Moving Average 200 Days | 2.09 |
Statistics
| Average Volume | 1.97M |
| Shares Outstanding | 7.45M |
| % Held by Institutions | 13.82 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | January 02, 2026 |
AD
